<DOC>
	<DOC>NCT02879019</DOC>
	<brief_summary>Whereas the efficacy of exercise interventions has been abundantly proven in male with peripheral artery disease (PAD), it remains to be determined whether these interventions are effective in women. The aim of this randomized controlled trial which will be performed with 34 PAD women will be to investigating the effects of 12 weeks of supervised walking on functional capacity and cardiovascular function and regulation at rest and during exercise.</brief_summary>
	<brief_title>Walking Training in Peripheral Artery Disease (GrEnADa Sub-study)</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Intermittent Claudication</mesh_term>
	<criteria>aanklebrachial index (ABI) â‰¤ 0.9 in one or two legs fontaine stage II of PAD body mass index &lt;35 kg/m2 resting systolic blood pressure (BP) &lt;160 mmHg and diastolic BP &lt;105 mmHg ability to walk at least 2min at 3.2 km/h ability to undertake an incremental treadmill test decrease of at least 15% in ABI after a maximal treadmill test not currently engaging in any regular exercise program exercise induced signs of myocardial ischemia or complex ventricular arrhythmias cardiovascular autonomic neuropathy use of betablocker, nondihydropyridine calcium antagonists or insulin and hormone replacement therapy.</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>